Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction. The TIMI Study Group. Thrombolysis in myocardial infarction
- PMID: 10520778
- DOI: 10.1016/s0735-1097(99)00335-6
Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction. The TIMI Study Group. Thrombolysis in myocardial infarction
Abstract
Objectives and background: While attention has focused on coronary blood flow in the culprit artery in acute myocardia infarction (MI), flow in the nonculprit artery has not been studied widely, in part because it has been assumed to be normal. We hypothesized that slower flow in culprit arteries, larger territories infarcted and hemodynamic perturbations may be associated with slow flow in nonculprit arteries.
Methods: The number of frames for dye to first reach distal landmarks (corrected TIMI [Thrombolysis in Acute Myocardial Infarction] frame count [CTFC]) were counted in 1,817 nonculprit arteries from the TIMI 4, 10A, 10B and 14 thrombolytic trials.
Results: Nonculprit artery flow was slowed to 30.9 +/- 15.0 frames at 90 min after thrombolytic administration, which is 45% slower than normal flow in the absence of acute MI (21 +/- 3.1, p < 0.0001). Patients with TIMI grade 3 flow in the culprit artery had faster nonculprit artery CTFCs than those patients with TIMI grades 0, 1 or 2 flow (29.1 +/- 13.7, n = 1,050 vs. 33.3 +/- 16.1, n = 752, p < 0.0001). The nonculprit artery CTFC improved between 60 and 90 min (3.3 +/- 17.9 frames, n = 432, p = 0.0001), and improvements were related to improved culprit artery flow (p = 0.0005). Correlates of slower nonculprit artery flow included a pulsatile flow pattern (i.e., systolic flow reversal) in the nonculprit artery (p < 0.0001) and in the culprit artery (p = 0.01), a left anterior descending artery culprit artery location (p < 0.0001), a decreased systolic blood pressure (p = 0.01), a decreased ventriculographic cardiac output (p = 0.02), a decreased double product (p = 0.0002), a greater percent diameter stenosis of the nonculprit artery (p = 0.01) and a greater percent of the culprit artery bed lying distal to the stenosis (p = 0.04). Adjunctive percutaneous transluminal coronary angioplasty (PTCA) of the culprit artery restored a culprit artery CTFC (30.4 +/- 22.2) that was similar to that in the nonculprit artery at 90 min (30.2 +/- 13.5), but both were slower than normal CTFCs (21 +/- 3.1, p < 0.0005 for both). If flow in the nonculprit artery was abnormal (CTFC > or = 28 frames) then the CTFC after PTCA in the culprit artery was 17% slower (p = 0.01). Patients who died had slower global CTFCs (mean CTFC for the three arteries) than patients who survived (46.8 +/- 21.3, n = 47 vs. 39.4 +/- 16.7, n = 1,055, p = 0.02).
Conclusions: Acute MI slows flow globally, and slower global flow is associated with adverse outcomes. Relief of the culprit artery stenosis by PTCA restored culprit artery flow to that in the nonculprit artery, but both were 45% slower than normal flow.
Similar articles
-
TIMI frame count: a quantitative method of assessing coronary artery flow.Circulation. 1996 Mar 1;93(5):879-88. doi: 10.1161/01.cir.93.5.879. Circulation. 1996. PMID: 8598078
-
Determinants of coronary blood flow after thrombolytic administration. TIMI Study Group. Thrombolysis in Myocardial Infarction.J Am Coll Cardiol. 1999 Nov 1;34(5):1403-12. doi: 10.1016/s0735-1097(99)00397-6. J Am Coll Cardiol. 1999. PMID: 10551685
-
Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study Group.Circulation. 1999 Apr 20;99(15):1945-50. doi: 10.1161/01.cir.99.15.1945. Circulation. 1999. PMID: 10208996 Clinical Trial.
-
Thrombolysis versus primary percutaneous transluminal coronary angioplasty for acute myocardial infarction.Cardiol Rev. 1999 Mar-Apr;7(2):77-82. doi: 10.1097/00045415-199903000-00010. Cardiol Rev. 1999. PMID: 10348969 Review.
-
Changing paradigms in thrombolysis in acute myocardial infarction.Int J Cardiol. 1997 May 23;59(3):227-42. doi: 10.1016/s0167-5273(97)02957-4. Int J Cardiol. 1997. PMID: 9183037 Review.
Cited by
-
Immediate multivessel revascularization may increase cardiac death and myocardial infarction in patients with ST-elevation myocardial infarction and multivessel coronary artery disease: data analysis from real world practice.Korean J Intern Med. 2016 May;31(3):488-500. doi: 10.3904/kjim.2014.119. Epub 2016 Apr 6. Korean J Intern Med. 2016. PMID: 27048252 Free PMC article.
-
Importance of the TIMI frame count: implications for future trials.Curr Control Trials Cardiovasc Med. 2000;1(1):31-34. doi: 10.1186/cvm-1-1-031. Curr Control Trials Cardiovasc Med. 2000. PMID: 11714404 Free PMC article.
-
Rapid progression of nonculprit coronary lesions six weeks after successful primary PCI in culprit artery: a case report.J Biomed Res. 2014 Mar;28(2):146-50. doi: 10.7555/JBR.28.20130155. Epub 2014 Mar 15. J Biomed Res. 2014. PMID: 24683412 Free PMC article.
-
Subclinical dysfunction of remote myocardium is related to high NT-proBNP and affects global contractility at follow-up, independently of infarct area.Front Cardiovasc Med. 2022 Dec 19;9:997821. doi: 10.3389/fcvm.2022.997821. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36601063 Free PMC article.
-
Thrombin activatable fibrinolysis inhibitor : its role in slow coronary flow.Herz. 2014 Dec;39(8):993-1000. doi: 10.1007/s00059-013-3942-8. Epub 2013 Sep 27. Herz. 2014. PMID: 24068025
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical